CIK 0001434647
- Non-accelerated filer
- Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205894398
- Phone
- +1 888-958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 4 Planned sale Chief Medical Officer sold 4,533 shares at $8.83 ($40,036)
- 4 Planned sale CCO sold 3,375 shares at $8.83 ($29,800)
- 4 Planned sale President and CEO sold 91,000 shares at $9.38 ($853,425)
- 4 Shares withheld for taxes Former CFO & Treasurer gave up 48,513 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 19,500 shares at $10.82 ($210,908)
- 4 Open-market buy Director bought 3,175 shares at $7.79 ($24,718)
- 4 Open-market buy Director bought 20,000 shares at $7.89 ($157,800)
- 4 Open-market buy Director bought 5,000 shares at $9.17 ($45,825)
- 4 Planned sale Chief Legal & Compliance sold 24,000 shares at $9.21 ($221,004)
- 4 Exercise or conversion Chief Legal & Compliance acquired 66,666 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 300 shares at $7.84 ($2,352)
Page 2 of 16 · 314 filings